Should Everyone be on GLP-1s?

Should Everyone be on GLP-1s?

Up next

Providing Rural Health Care Is Really Hard; 60 Million Americans Rely on It

Approximately 1 in 5 Americans live in rural areas, and in the coming years they will see dramatic shifts in their health care options due to the One Big Beautiful Bill Act. In this episode of Healthy Dialogue Mark Holmes, PhD, joins host Derek C. Angus, MD, MPH, to explore the i ...  Show more

Long COVID: the problem society wants to forget

Long COVID is a debilitating condition impacting millions of people around the world, but is still poorly understood, poorly defined, and poorly treated. In this episode of Healthy Dialogue, host Derek C. Angus, MD, MPH, discusses long COVID with Wes Ely, MD, MPH, professor of me ...  Show more

Recommended Episodes

Randomized Trial of Anti-VEGF to Prevent Proliferative Diabetic Retinopathy (PDR) and Diabetic Macular Edema (DME)
JAMA Ophthalmology Author Interviews

Interview with Raj K Maturi, MD, and Jennifer K Sun, MD, authors of Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial and with Howa ...  Show more

November 2021: Issue Summary 1
Radiology Podcast | RSNA

Dr. Lauren Kim interviews Dr. Florian Gassert and Dr. Theresa Urban. X-ray Dark-Field Chest Imaging: Qualitative and Quantitative Results in Healthy Humans. Gassert and Urban et al. Radiology 2021; 301:389–395. Introduction by Dr. Linda Chu 

USPSTF Recommendation: Interventions for High BMI in Children and Adolescents
JAMA Clinical Reviews

Interview with John M. Ruiz, PhD, USPSTF member and coauthor of Management of BMI in Children: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.

Related Content:

< ...  Show more

Time to Significant Benefit of Finerenone in Patients with Heart Failure | HFSA 2024
JACC This Week

Michelle M Kittleson, MD, FACC, JACC Associate Editor, speaks with author Muthiah Vaduganathan, MD on his accepted paper concerning the FINEARTS trial published in JACC.